The use of midazolam and haloperidol in cancer patients at the end of life.

Abstract

INTRODUCTION This study aimed to describe the patterns of sedative use among terminally ill cancer patients who were referred to a hospital-based specialist palliative care service for symptom management. It also aimed to examine whether sedative use among terminally ill cancer patients during the last two days of life had any impact on their survival… (More)

Topics

8 Figures and Tables

Slides referencing similar topics